Skip to main content

Genedata acquired by Danaher

| News

Genedata acquired by Danaher

20.08.2024

The Basel-based biotechnology company Genedata has been taken over by the Danaher Corporation in the USA. With this takeover, the Danaher portfolio will be bolstered by the expertise of Genedata in the field of life sciences software solutions.

Genedata, a specialist in the development of life sciences software solutions based in Basel, has been taken over by Danaher Corporation from Washington D.C. in the USA. As detailed in a press release, the software solutions and expertise from Genedata are intended to supplement the broad spectrum of workflow solutions offered by Danaher. The two companies have already been successfully collaborating on software solutions for implementation in new therapies and diagnostic methods over the past few years.

“Genedata is a global market leader in digitalizing R&D processes to help accelerate the delivery of lifesaving and personalized medicines”, as Othmar Pfannes, founder and CEO of Genedata, comments in the press release. “As a Danaher operating company, Genedata will seek to continue to attract the brightest talent and solve our customers’ hardest problems globally”, he adds.

Innovative software solutions

Greg Milosevich, Vice President and Group Executive of Danaher’s DH Life Sciences LLC, was delighted that the innovative software solutions developed by Genedata will support biopharmaceutical companies in the development of urgently needed therapies. “We are excited to welcome their team to Danaher and intend to continue expanding Genedata’s capabilities to address new technologies and requirements in this quickly evolving field”, Milosevich states.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Building the future of healthtech, digital health and techbio in the Basel Area

Meet our Chief Representative USA: with over 30 years in the biotech industry, Kirsten Detrick brings invaluable expertise for companies...
Read More

The power of a persuasive pitch deck

Are you an entrepreneur striving to secure investment for your biotech startup? Start with an effective pitch deck to catch...
Read More

Roche investing an additional 1.2 billion Swiss francs in Basel

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...
Read More

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

Do you have a question? We'd like to hear from you.